首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Survival trends in ESRD patients compared with the general population in the United States
【24h】

Survival trends in ESRD patients compared with the general population in the United States

机译:ESRD患者的生存趋势与美国一般人群相比

获取原文
获取原文并翻译 | 示例
           

摘要

Background Health care resources expended on patients with end-stage renal disease (ESRD) have increased extensively, with uncertain changes in outcomes. In this study, we examined survival trends in the United States in patients with ESRD receiving renal replacement therapy with long-term dialysis or transplantation relative to the general population. Study Design Secondary analysis of records from the US Renal Data System. Setting & Participants American adults receiving renal replacement therapy in 1977, 1987, 1997, and 2007. Predictor Year. Outcome 1-year survival. Measurements Abridged period life tables were created for each cross-sectional patient group and were compared with general US population life tables to measure relative survival, calculated as differences in average survival between the general US and the ESRD populations. Results From 1977 to 2007, ESRD patient groups became significantly older (mean age increased from 47 to 58 years) and sicker (ESRD due to diabetes increased from 9.1% to 38.2%; patients with a high death risk increased from 36.8% to 50.7%). Unadjusted age-specific survival improved (for 50-year-olds, average life expectancy increased 8% from 7.3 years in 1977 to 7.9 years in 2007), but age-specific survival increased more extensively in the general US population (from 27.5 years in 1977 to 30.9 years in 2007; 12% improvement). Accounting for this, age-specific relative survival in patients with ESRD decreased (for 50-year-olds, 20.2 life-years lost in 1977 vs 23.0 life-years lost in 2007). Limitations Our analysis controlled for neither patient comorbid conditions nor initial glomerular filtration rate at the start of renal replacement therapy. Conclusions Over the past 4 decades, age-specific survival in patients with ESRD has improved, but has not kept pace with that of the general US population. To be complete, future survival studies in patients with ESRD should focus on both temporal changes in survival within this group and changes relative to the general population.
机译:背景技术临床肾病(ESRD)患者的保健资源广泛增加,结果不确定发生变化。在这项研究中,我们在患有ESRD接受肾脏替代治疗的患者中检查了美国的生存趋势,相对于一般人群进行移植。研究美国肾脏数据系统记录的二次分析。环境与参与者在1977年,1987年,1997年和2007年接受肾替换疗法的美国成人。预测年度。结果1年生存。测量为每个横截面患者组创建了销售时间寿命表,并与美国通用人口寿命表进行了比较,以测量相对存活,计算为美国和ESRD群体之间平均生存的差异。结果1977年至2007年,ESRD患者群体变得较大(平均年龄从47至58岁增加)和病情(由于糖尿病患者增加到38.2%);死亡率高的患者从36.8%增加到50.7% )。未经调整的年龄特异性生存改善(为50岁,平均预期寿命从1977年的777年增加了8%至2007年的7.9岁),但年龄特异性的生存在美国人口总体上更广泛地增加(27.5岁) 1977年至2007年30年9年; 12%的改善)。核算这一点,ESRD患者的年龄特异性相对生存(为50岁,1977年迷失了20.2岁生命年龄)2007年迷失了23.0岁生命年份)。局限性我们的分析控制既不控制患者的合并条件也不是肾置换疗法开始时的初始肾小球过滤速率。结论在过去的4个十年中,ESRD患者的年龄特异性生存率有所改善,但并未与美国普通人口的速度保持不足。要完成,ESRD患者的未来存活研究应专注于本集团内存中的暂时变化,以及相对于一般人群的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号